Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer

Journal of Gastroenterology

Volumn 33, Issue 3, 1998, Pages 349-353

  Yamaguchi, Akio ^a   Goi, Takanori ^a   Taguchi, Seiichi ^a   Ohtaki, Norio ^a   Seki, Kenichiro ^a   Hirose, Kazuo ^a   Nakagawara, Gizo ^a   Urano, Takeshi ^b   Furukawa, Koichi ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44v8 10; Colorectal cancer; Liver metastasis; Variant CD44

Indexed keywords

CD44V ANTIGEN; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; CANCER INVASION; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIGENS, CD44; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031777282     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050095     Document Type: Article

References (23)

1. Goldstein LA, Zhou DFH, Picker LJ, et al. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989;56:1063-1072.
2. Hale LP, Singer KH, Haynes BF. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erytarocytes to T cells. J Immunol 1989;143: 3944-3948.
3. Aruffo A, Stamenkovic I, Melnick M, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
4. St John T, Meyer J, Idzerda R, et al. Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 1990;60:45-52.
5. Miyake K, Medina KL, Hayashi S, et al. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 1990;171:477-488.
6. Hofmann M, Rudy W, Zöller M, et al. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292-5297.
7. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
8. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-12164.
9. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992;267:4732-4739.
10. Tölg C, Hofmann M, Herrlich P, et al. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993;21:1225-1229.
11. Heider K-H, Hofmann M, Hors E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993;120:227-230.
12. Tanabe KK, ElisEllis LM, Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993;341:725-726.
13. Wielenga VJM, Heider K-H, Offerhaus GJA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-4756.
14. Yamaguchi A, Urano T, Goi T, et al. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 1996;14:1122-1127.
15. Guo Y-J, Liu G, Wang X, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994;54:422-426.
16. Goi T, Yamaguchi A, Takeuchi K, et al. CD44 with variant exons 8-10 in colorectal tumors: Expression analysis by a variant exon 9-specific monoclonal antibody. Int J Oncol 1996;8:657-662.
17. Takeuchi K, Yamaguchi A, Urano T, et al. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res 1995;86:292-297.
18. Ristamäki R, Joensuu H, Salmi M, et al. Serum CD44 in malignant lymphoma: An association with treatment response. Blood 1994;84:238-243.
19. Kainz C, Tempfer C, Winkler S, et al. Serum CD44 splice variants in cervical cancer patients. Cancer Lett 1995;90:231-234.
20. Sliutz G, Tempfer C, Winkler S, et al. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer 1995;72:1494-1497.
21. Kan M, Kanayama H, Naruo S, et al. Serological evaluation of soluble CD44 in renal cancer. Jpn J Cancer Res 1996;87:1191-1194.
22. Seki K, Yamaguchi A, Goi T, et al. Inhibition of liver metastasis formation by anti-CD44 variant exon 9 monoclonal antibody. Int J Oncol 1997;11:1257-1261.
23. Japanese Research Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 5th ed. Tokyo: Kanehara, 1994.